Sensei Biotherapeutics Inc

Research Sensei Biotherapeutics Inc (SNSE) on Bullrun: market cap USD 28.85M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerSNSE
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 28.85M
• Financial periodFY2025
• Net income-USD 21.09M
• Free cash flow-USD 20.47M

Valuation Snapshot

latest market cap is USD 28.85M.

About Sensei Biotherapeutics Inc

Sensei Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery and development of therapeutics for cancer patients. The company offers PIKTOR, an investigational multi-node inhibitor of the PI3K/AKT/mTOR pathway in development for endometrial and breast cancer. It offers Solnerstotug, an active monoclonal antibody that is in clinical Phase 1/2 targeting the immune checkpoint VISTA for the treatment of solid tumors.

Frequently asked questions

What is Sensei Biotherapeutics Inc's market cap?

Sensei Biotherapeutics Inc's market capitalization is USD 28.85M.

What does Sensei Biotherapeutics Inc do?

Sensei Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery and development of therapeutics for cancer patients. The company offers PIKTOR, an investigational multi-node inhibitor of the PI3K/AKT/mTOR pathway in development for endometrial and breast cancer.